4 May 2020 - The chair of a House of Representatives committee and a fellow Democratic committee member on Monday urged Jaguar Health Inc to reverse recent price hikes of a drug that could be used to treat side effects in COVID-19 patients and asked that Jaguar provide information on the price increases.
In a letter to Jaguar, Representative Carolyn Maloney, chair of the House Oversight and Reform Committee, and Representative Jackie Speier criticized Jaguar for what they said was a nearly threefold price increase of the drug, Mytesi, from $688.52 to $2,206.52 per bottle of pills, in early April.
They asked Jaguar to provide all communications pertaining to the price increases to the Committee on Oversight and Reform by May 18.